灌注成像无复流现象:区分急性卒中功能与组织结局的阈值
本研究基于两项前瞻性多中心影像注册数据,纳入血管内取栓后成功再通(mTICI 2c/3)的急性卒中患者,于术后24小时行CT或MR灌注成像,评估多种无复流定义对90天功能结局的判别能力。结果显示,延迟时间(DT)大于4秒的病灶对不良功能结局判别力最强(AUC 0.72),且与梗死增长相关;该定义下21%患者存在无复流,其不良结局风险显著增高(OR 12.14)。
要点
- 取栓成功再通后24小时灌注成像上DT>4秒的残留低灌注病灶提示无复流现象。
- DT>4秒定义的无复流与90天不良功能结局独立相关(OR 12.14),并伴梗死体积增长。
- 阅片时需关注灌注图上延迟时间参数,识别再通后仍存在的功能性微循环障碍。
关键影像表现/征象
- 术后24小时灌注成像上DT>4秒的残留低灌注病灶对不良90天功能结局判别力最强(AUC 0.72,95%CI 0.57-0.86;P<.001)。
- 按DT>4秒定义,67例中14例(21%)存在无复流;无复流组不良功能结局11/14(79%),复流组11/53(21%)。
- 无复流组梗死增长中位数24.1 mL(IQR 3.7-40.7 mL),复流组0 mL(IQR -10.1至6.1 mL),P<.001。
诊断标准与关键数值
- 无复流定义:术后24小时灌注成像上存在延迟时间(DT)>4秒的残留低灌注病灶。
- DT>4秒定义下无复流与不良功能结局的OR为12.14(95%CI 3.38-54.63),P<.001。
- 主要结局为90天不良功能结局(mRS>2);梗死增长为次要结局。
临床应用与阅片要点
- 对EVT成功再通患者,术后24小时灌注成像应关注DT参数图,识别DT>4秒的残留低灌注区。
- 发现DT>4秒病灶提示无复流现象,需在报告中提示临床预后不良风险及梗死增长可能。
- 候选无复流定义在八种灌注图及阶梯阈值中筛选,DT>4秒为最优组合,独立队列结果一致。
局限性
- 本研究为二次分析,样本量有限(主要队列67例,独立队列54例)。
- 无复流定义基于灌注成像参数阈值,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Poor outcome after successful endovascular thrombectomy (EVT) may reflect microvascular dysfunction, or no-reflow phenomenon, but operational definitions are lacking. Purpose To identify the most informative candidate no-reflow definition at 24-hour post-EVT perfusion imaging for outcome assessment. Materials and Methods This secondary analysis used data from two prospective multicenter imaging registries of patients with acute stroke who were recruited between June 2016 and July 2022, achieved modified thrombolysis in cerebral infarction grade 2c or 3 recanalization after EVT, and underwent pre-EVT and 24-hour post-EVT CT or MR perfusion imaging. Candidate no-reflow definitions were evaluated across eight perfusion maps and their corresponding stepwise thresholds. Delay time (DT) quantifies the delay in contrast material arrival between arterial input and brain tissue. For primary screening, no-reflow status was defined as any residual hypoperfusion lesion for each map-threshold combination. The best-performing combination was evaluated using residual volume and reperfusion index cutoffs. The primary outcome was poor 90-day functional outcome (modified Rankin Scale score >2); infarct growth was secondary. Associations with the outcome were evaluated using multivariable Firth penalized logistic regression. Results The primary cohort included 67 patients (median age, 69 years [IQR, 56-77 years]; 41 male), and the independent cohort comprised 54 patients (median age, 69 years [IQR, 62-78 years]; 28 female). In the primary cohort, lesions with DT longer than 4 seconds showed the strongest discrimination for poor 90-day functional outcome (area under the receiver operating characteristic curve, 0.72 [95% CI: 0.57, 0.86]; P < .001). According to this definition, 14 of 67 patients (21%) had no reflow. Poor functional outcome occurred in 11 of 14 patients (79%) with no reflow and 11 of 53 (21%) with reflow (odds ratio, 12.14 [95% CI: 3.38, 54.63]; P < .001). Infarct growth was greater with no-reflow status than with reflow (median, 24.1 mL [IQR, 3.7-40.7 mL] vs 0 mL [IQR, -10.1 to 6.1 mL]; P < .001). Findings were consistent in the independent cohort. Conclusion The presence of a lesion with DT longer than 4 seconds at 24-hour post-EVT perfusion imaging appeared to be the most informative candidate no-reflow definition. © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Gemmete in this issue.
引用
- Xu T, Chen C, Manning NW, et al. No Reflow at Perfusion Imaging: Thresholds That Distinguish Functional and Tissue Outcome Groups in Acute Stroke. Radiology. 2026. PMID: 42899936. doi:10.1148/radiol.253025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。